Table 2. Glucocorticoid and Mineralocorticoid Replacement Therapy in Primary Adrenal Insufficiency Patients.
Type of treatment | No. of patients (%) | Regimen | Median daily dose, mg | |
---|---|---|---|---|
Frequency/day | No. of patients (%) | |||
Glucocorticoid replacement | 245 (91.1) | |||
Prednisolone | 170 (69.4) | q.d. | 132 (77.6) | 7.5 |
b.i.d. | 38 (22.4) | |||
Hydrocortisone | 65 (26.5) | q.d. | 12 (18.5) | 20 |
b.i.d. | 50 (76.9) | |||
t.i.d. | 3 (4.6) | |||
Dexamethasone | 5 (2.0) | q.d. | 3 (60.0) | 4 |
b.i.d. | 2 (40.0) | |||
Deflazacort | 2 (0.8) | q.d. | 2 (100.0) | 7.5 |
Unknown | 3 (1.2) | - | - | - |
Mineralocorticoid replacement | 73 (27.1) | q.d. | 73 (100.0) | 0.1 |
Values are expressed as number (%).
q.d., once daily; b.i.d., twice daily; t.i.d., 3 times daily.